New Jersey court upholds $25 million Accutane verdict 
Published: September 28, 2011
Tags: Accutane, IBD, inflammatory bowel disease
Denying a defense motion for remittitur or new trial, a New Jersey judge has affirmed a jury’s $25.16 million award to an Alabama man who suffered from inflammatory bowel disease as a result of taking the acne medication Accutane.
Accutane verdicts: $2 million for one plaintiff out of three
By:
Correy Stephenson
Published: April 22, 2011
Tags: Accutane, Crohn’s disease, drug litigation, failure to warn, Hoffman-LaRoche, IBD, inflammatory bowel disease
In a trio of cases tried together against Hoffman-LaRoche, the maker of Accutane, jurors awarded just one of the plaintiffs suffering from inflammatory bowel disease $2.1 million.
Drug litigation in review 2010
By:
Tony Ogden
Published: January 4, 2011
Tags: Accutane, Allergan, antidepressant, Avandia, AztraZeneca, Botox, Botox litigation, Department of Justice, DOJ, epilepsy, failure to warn, GlaxoSmithKline, heart attack, hormone replacement therapy, hormone replacement therapy litigation, Johnson & Johnson, Levaquin, Neurontin, Paxil, Pfizer, Premarin, Prempro, Provera, Roche, Seroquel, Wyeth
Much like 2009, 2010 was a busy year for prescription drug suits.
Accutane suits pile up
By:
Correy Stephenson
Published: October 20, 2010
Tags: Accutane, product liability
Several hundred more lawsuits were filed recently in the New Jersey mass tort against Roche, the maker of acne drug Accutane, alleging that the company failed to adequately warn users of the potential for serious side effects including Crohn’s disease, ulcerative colitis and inflammatory bowel disease.
$10.5 million Accutane verdict reversed
By:
Correy Stephenson
Published: August 10, 2010
Tags: Accutane, inflammatory bowel disease, product liability
A trial judge improperly limited the defense’s evidence regarding the overall number of Accutane users, the New Jersey Appellate Division has ruled in reversing a $10.5 million verdict for the plaintiff.
Roche defendants move for settlement approval in Accutane suit
By:
Tony Ogden
Published: May 12, 2010
Tags: Accutane, medical malpractice, product liability
The makers of an acne drug at the heart of a medical malpractice and product liability suit have asked that their settlement with plaintiff Jason Peipert be approved.
Last defendant in long-running Accutane suit settles
By:
Pat Murphy
Published: April 21, 2010
Tags: Accutane
A nearly seven-year old suit over an acne medication is over. The last defendant in a Madison County, Illinois, product liability-medical malpractice case involving Accutane settled as it was set to go to trial on Monday.
N.J. jury awards $25 million to Accutane user with IBD
By:
Nora Tooher
Published: February 25, 2010
Tags: Accutane, inflammatory bowel disease, Roche Laboratories
In a retrial, a New Jersey jury has awarded $25.16 million – nearly 10 times the original award – to an Alabama man with inflammatory bowel disease.
Expert can’t testify about Accutane study
By:
Nora Tooher
Published: February 8, 2010
Tags: Accutane, causation, expert testimony, product liability
A plaintiff’s expert can’t testify regarding a study showing a link between the drug Accutane and depression, but may be able to testify on general causation, the New Jersey Appellate Division has ruled.
Accutane verdict reversed for lack of evidence
By:
Correy Stephenson
Published: November 20, 2009
Tags: Accutane, drug litigation, failure to warn
A plaintiff who sued the maker of Accutane failed to establish evidence at trial that a differently worded warning would have resulted in his physician not prescribing the drug, the Florida Court of Appeals has ruled in reversing a $7 million award.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
